Company record
Preferred Pharmaceuticals, Inc.
0 FDA warning letters since 2023 and 4 recalls in the last 12 months.
Get an email the day FDA posts anything new about Preferred Pharmaceuticals, Inc..
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| Nov 11 | Class II | Preferred Pharmaceuticals, Inc. Drug |
Artificial Tears Lubricant Eye Drops, Visine, Pkg Size: 15, Mfg: Geri-Care: Brooklyn, NY. NDC: 68788-7266-0 Lack of Assurance of Sterility |
| Oct 14 | Class II | Preferred Pharmaceuticals, Inc. Drug |
Lidocaine Ointment USP, 5% (Generic for Xylocaine), packaged in a 50 g jar, Rx only, Mfg: Taro Pharmaceuticals U.S.A., Inc., Prod# (NDC): 68788-7865-05 Failed Content Uniformity Specifications |
| Apr 15 | Class II | Preferred Pharmaceuticals, Inc. Drug |
Artificial Tears Lubricant Eye Drops (glycerin 0.2%, hypromellose 0.2%, polyethylene glycol 400 1%), 0.5 oz bottles, Mfg: Geri-Care; Brooklyn, New York NDC 68788-7266-0 Lack of Assurance of Sterility |
| Dec 24, 2025 | Class II | Preferred Pharmaceuticals, Inc. Drug |
Ondansetron ODT Tablets, USP 4mg, 1x10 unit dose tablets, Mfg: Glenmark Pharmaceuticals Limited, Repackaged by Preferred Pharmaceuticals NDC 68788-8666-01 Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale. |